MEI Pharma, Inc. (MEIP): Price and Financial Metrics


MEI Pharma, Inc. (MEIP): $0.41

0.09 (+26.88%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

MEIP POWR Grades

  • Value is the dimension where MEIP ranks best; there it ranks ahead of 80.98% of US stocks.
  • The strongest trend for MEIP is in Sentiment, which has been heading up over the past 105 days.
  • MEIP ranks lowest in Momentum; there it ranks in the 3rd percentile.

MEIP Stock Summary

  • Of note is the ratio of MEI PHARMA INC's sales and general administrative expense to its total operating expenses; just 11.62% of US stocks have a lower such ratio.
  • The volatility of MEI PHARMA INC's share price is greater than that of 97.34% US stocks with at least 200 days of trading history.
  • MEI PHARMA INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -108.75%, greater than the shareholder yield of only 5.51% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to MEI PHARMA INC, a group of peers worth examining would be AYLA, VTGN, TCRX, SYBX, and PRQR.
  • Visit MEIP's SEC page to see the company's official filings. To visit the company's web site, go to www.meipharma.com.

MEIP Valuation Summary

  • In comparison to the median Healthcare stock, MEIP's price/sales ratio is 75% lower, now standing at 1.2.
  • Over the past 230 months, MEIP's price/sales ratio has gone down 5982.7.

Below are key valuation metrics over time for MEIP.

Stock Date P/S P/B P/E EV/EBIT
MEIP 2022-11-25 1.2 1.3 -0.9 1.4
MEIP 2022-11-23 1.2 1.4 -1.0 1.4
MEIP 2022-11-22 1.2 1.3 -0.9 1.4
MEIP 2022-11-21 1.2 1.3 -0.9 1.4
MEIP 2022-11-18 1.2 1.4 -1.0 1.4
MEIP 2022-11-17 1.3 1.4 -1.0 1.3

MEIP Growth Metrics

    The 2 year net cashflow from operations growth rate now stands at -3.68%.
  • The 4 year revenue growth rate now stands at -75.19%.
  • Its 2 year cash and equivalents growth rate is now at 82.16%.
MEIP's revenue has moved up $37,126,000 over the prior 33 months.

The table below shows MEIP's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 41.67 -55.807 -53.568
2022-06-30 40.697 -48.746 -54.454
2022-03-31 36.737 -44.499 -46.769
2021-12-31 44.143 -43.19 -54.675
2021-09-30 35.088 -30.574 -60.363
2021-06-30 25.535 -31.964 -50.575

MEIP's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MEIP has a Quality Grade of C, ranking ahead of 61.23% of graded US stocks.
  • MEIP's asset turnover comes in at 0.131 -- ranking 236th of 682 Pharmaceutical Products stocks.
  • BLUE, BPMC, and NERV are the stocks whose asset turnover ratios are most correlated with MEIP.

The table below shows MEIP's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.131 0.945 -34.832
2021-03-31 0.201 0.954 -23.189
2020-12-31 0.220 0.941 -19.061
2020-09-30 0.201 0.921 -34.437
2020-06-30 0.240 0.908 10.741
2020-03-31 0.051 0.275 3.585

MEIP Price Target

For more insight on analysts targets of MEIP, see our MEIP price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $10.67 Average Broker Recommendation 1.39 (Strong Buy)

MEIP Stock Price Chart Interactive Chart >

Price chart for MEIP

MEIP Price/Volume Stats

Current price $0.41 52-week high $2.86
Prev. close $0.33 52-week low $0.28
Day low $0.32 Volume 6,424,400
Day high $0.43 Avg. volume 2,931,111
50-day MA $0.36 Dividend yield N/A
200-day MA $0.67 Market Cap 55.29M

MEI Pharma, Inc. (MEIP) Company Bio


MEI Pharma, Inc., an oncology company, focuses on the clinical development of drugs for the treatment of cancer. The company was founded in 2000 and is based in San Diego, California.


MEIP Latest News Stream


Event/Time News Detail
Loading, please wait...

MEIP Latest Social Stream


Loading social stream, please wait...

View Full MEIP Social Stream

Latest MEIP News From Around the Web

Below are the latest news stories about MEI PHARMA INC that investors may wish to consider to help them evaluate MEIP as an investment opportunity.

MEI Pharma Inc. (MEIP) will benefit from these strategies

In Monday’s session, MEI Pharma Inc. (NASDAQ:MEIP) marked $0.38 per share, down from $0.39 in the previous session. While MEI Pharma Inc. has underperformed by -3.82%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, MEIP fell by -86.51%, with highs and lows ranging from $3.55 to […]

US Post News | November 22, 2022

MEI Pharma Inc. (MEIP) Has Strong Growth Prospects Through 2022

MEI Pharma Inc. (NASDAQ:MEIP) has a beta value of 0.86 and has seen 1.79 million shares traded in the last trading session. The company, currently valued at $53.70M, closed the last trade at $0.39 per share which meant it lost -$0.01 on the day or -3.20% during that session. The MEIP stock price is -810.26% … MEI Pharma Inc. (MEIP) Has Strong Growth Prospects Through 2022 Read More »

Marketing Sentinel | November 21, 2022

MEI Pharma First Quarter 2023 Earnings: Beats Expectations

MEI Pharma ( NASDAQ:MEIP ) First Quarter 2023 Results Key Financial Results Revenue: US$8.73m (up 13% from 1Q 2022...

Yahoo | November 20, 2022

Analysts Just Published A Bright New Outlook For MEI Pharma, Inc.'s (NASDAQ:MEIP)

Shareholders in MEI Pharma, Inc. ( NASDAQ:MEIP ) may be thrilled to learn that the analysts have just delivered a major...

Yahoo | November 19, 2022

Kyowa Kirin and MEI Pharma Announce Topline Data from the Phase 2 MIRAGE Study Evaluating Zandelisib in Patients with Indolent B-cell non-Hodgkin’s Lymphoma in Japan

Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical company creating innovative medical solutions utilizing the latest b

Business Wire | November 18, 2022

Read More 'MEIP' Stories Here

MEIP Price Returns

1-mo 26.54%
3-mo N/A
6-mo -35.14%
1-year -83.67%
3-year -78.87%
5-year -81.78%
YTD -84.64%
2021 1.14%
2020 6.45%
2019 -6.06%
2018 25.71%
2017 45.83%

Continue Researching MEIP

Want to see what other sources are saying about MEI Pharma Inc's financials and stock price? Try the links below:

MEI Pharma Inc (MEIP) Stock Price | Nasdaq
MEI Pharma Inc (MEIP) Stock Quote, History and News - Yahoo Finance
MEI Pharma Inc (MEIP) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8651 seconds.